Types of studies and participants: We included randomized (RCT) and non-randomized clinical trials (nRCT) comparing therapy with IV iron with or without (EPO) versus placebo in HF patients with ID regardless of left ventricular ejection fraction (LVEF), aged 18 years and above. Here, EPO is linked to hydrops fetalis.